nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CYP1A2—Anagrelide—hematologic cancer	0.0411	0.0495	CbGbCtD
Hexobarbital—PTGS1—Bortezomib—hematologic cancer	0.0391	0.0471	CbGbCtD
Hexobarbital—PTGS1—Thalidomide—hematologic cancer	0.0341	0.041	CbGbCtD
Hexobarbital—PTGS1—Ifosfamide—hematologic cancer	0.03	0.0361	CbGbCtD
Hexobarbital—PTGS1—Imatinib—hematologic cancer	0.0286	0.0345	CbGbCtD
Hexobarbital—CYP2E1—Thalidomide—hematologic cancer	0.0263	0.0317	CbGbCtD
Hexobarbital—CYP2C9—Bexarotene—hematologic cancer	0.0257	0.0309	CbGbCtD
Hexobarbital—CHRFAM7A—ovarian follicle—hematologic cancer	0.0228	0.302	CbGeAlD
Hexobarbital—CYP2E1—Dacarbazine—hematologic cancer	0.0226	0.0272	CbGbCtD
Hexobarbital—CYP1A2—Carmustine—hematologic cancer	0.0216	0.026	CbGbCtD
Hexobarbital—CYP2C9—Idarubicin—hematologic cancer	0.0213	0.0256	CbGbCtD
Hexobarbital—CYP2C19—Bortezomib—hematologic cancer	0.0189	0.0228	CbGbCtD
Hexobarbital—CHRNA7—ovarian follicle—hematologic cancer	0.0184	0.244	CbGeAlD
Hexobarbital—CYP1A2—Methoxsalen—hematologic cancer	0.0184	0.0221	CbGbCtD
Hexobarbital—CYP2E1—Mitoxantrone—hematologic cancer	0.0176	0.0211	CbGbCtD
Hexobarbital—CYP1A2—Bortezomib—hematologic cancer	0.0175	0.021	CbGbCtD
Hexobarbital—CYP1A2—Daunorubicin—hematologic cancer	0.0167	0.0201	CbGbCtD
Hexobarbital—CYP2C19—Thalidomide—hematologic cancer	0.0165	0.0198	CbGbCtD
Hexobarbital—CYP1A2—Alitretinoin—hematologic cancer	0.0164	0.0197	CbGbCtD
Hexobarbital—CYP2C9—Bortezomib—hematologic cancer	0.0157	0.0189	CbGbCtD
Hexobarbital—CYP2C19—Teniposide—hematologic cancer	0.0157	0.0189	CbGbCtD
Hexobarbital—CYP1A2—Thalidomide—hematologic cancer	0.0152	0.0183	CbGbCtD
Hexobarbital—CYP3A4—Bexarotene—hematologic cancer	0.0149	0.018	CbGbCtD
Hexobarbital—CYP2C19—Ifosfamide—hematologic cancer	0.0145	0.0175	CbGbCtD
Hexobarbital—PTGS1—Etoposide—hematologic cancer	0.0143	0.0172	CbGbCtD
Hexobarbital—CYP3A4—Lomustine—hematologic cancer	0.0139	0.0167	CbGbCtD
Hexobarbital—CYP3A4—Busulfan—hematologic cancer	0.0139	0.0167	CbGbCtD
Hexobarbital—CYP2C19—Imatinib—hematologic cancer	0.0139	0.0167	CbGbCtD
Hexobarbital—CYP2C9—Thalidomide—hematologic cancer	0.0137	0.0165	CbGbCtD
Hexobarbital—CYP1A2—Dacarbazine—hematologic cancer	0.0131	0.0157	CbGbCtD
Hexobarbital—CYP2C9—Teniposide—hematologic cancer	0.0131	0.0157	CbGbCtD
Hexobarbital—CYP1A2—Imatinib—hematologic cancer	0.0128	0.0154	CbGbCtD
Hexobarbital—CYP3A4—Thiotepa—hematologic cancer	0.0124	0.0149	CbGbCtD
Hexobarbital—CYP2C9—Ifosfamide—hematologic cancer	0.0121	0.0145	CbGbCtD
Hexobarbital—CYP2C9—Imatinib—hematologic cancer	0.0115	0.0139	CbGbCtD
Hexobarbital—CYP2E1—Etoposide—hematologic cancer	0.0111	0.0133	CbGbCtD
Hexobarbital—CYP2C9—Nilotinib—hematologic cancer	0.0105	0.0126	CbGbCtD
Hexobarbital—CYP1A2—Dasatinib—hematologic cancer	0.0103	0.0124	CbGbCtD
Hexobarbital—CYP3A4—Methoxsalen—hematologic cancer	0.00962	0.0116	CbGbCtD
Hexobarbital—CYP3A4—Bortezomib—hematologic cancer	0.00915	0.011	CbGbCtD
Hexobarbital—CYP2C19—Prednisone—hematologic cancer	0.00914	0.011	CbGbCtD
Hexobarbital—CYP2E1—Dexamethasone—hematologic cancer	0.0091	0.011	CbGbCtD
Hexobarbital—CYP3A4—Daunorubicin—hematologic cancer	0.00875	0.0105	CbGbCtD
Hexobarbital—CYP3A4—Cytarabine—hematologic cancer	0.00772	0.00929	CbGbCtD
Hexobarbital—CYP3A4—Teniposide—hematologic cancer	0.00761	0.00915	CbGbCtD
Hexobarbital—CYP3A4—Ifosfamide—hematologic cancer	0.00702	0.00845	CbGbCtD
Hexobarbital—CYP3A4—Imatinib—hematologic cancer	0.0067	0.00807	CbGbCtD
Hexobarbital—CYP1A2—Etoposide—hematologic cancer	0.0064	0.00771	CbGbCtD
Hexobarbital—CYP3A4—Ruxolitinib—hematologic cancer	0.00631	0.0076	CbGbCtD
Hexobarbital—CYP3A4—Nilotinib—hematologic cancer	0.00609	0.00733	CbGbCtD
Hexobarbital—CYP3A4—Vinorelbine—hematologic cancer	0.00604	0.00727	CbGbCtD
Hexobarbital—CYP2C9—Cisplatin—hematologic cancer	0.00587	0.00707	CbGbCtD
Hexobarbital—CYP2C19—Dexamethasone—hematologic cancer	0.0057	0.00687	CbGbCtD
Hexobarbital—CYP3A4—Triamcinolone—hematologic cancer	0.00553	0.00665	CbGbCtD
Hexobarbital—CYP3A4—Dasatinib—hematologic cancer	0.00539	0.00648	CbGbCtD
Hexobarbital—CYP3A4—Mitoxantrone—hematologic cancer	0.00532	0.0064	CbGbCtD
Hexobarbital—CYP2C9—Dexamethasone—hematologic cancer	0.00474	0.00571	CbGbCtD
Hexobarbital—CYP3A4—Betamethasone—hematologic cancer	0.00474	0.00571	CbGbCtD
Hexobarbital—CYP3A4—Prednisolone—hematologic cancer	0.00468	0.00563	CbGbCtD
Hexobarbital—CYP3A4—Prednisone—hematologic cancer	0.00442	0.00532	CbGbCtD
Hexobarbital—CYP3A4—Irinotecan—hematologic cancer	0.00419	0.00504	CbGbCtD
Hexobarbital—CYP3A4—Vinblastine—hematologic cancer	0.00372	0.00448	CbGbCtD
Hexobarbital—CYP3A4—Vincristine—hematologic cancer	0.00366	0.00441	CbGbCtD
Hexobarbital—CYP3A4—Etoposide—hematologic cancer	0.00335	0.00404	CbGbCtD
Hexobarbital—CYP3A4—Dexamethasone—hematologic cancer	0.00276	0.00332	CbGbCtD
Hexobarbital—CHRFAM7A—hematopoietic system—hematologic cancer	0.00276	0.0365	CbGeAlD
Hexobarbital—CYP3A4—Doxorubicin—hematologic cancer	0.00229	0.00275	CbGbCtD
Hexobarbital—CHRNA7—hematopoietic system—hematologic cancer	0.00223	0.0294	CbGeAlD
Hexobarbital—CHRNA4—hematopoietic system—hematologic cancer	0.0022	0.029	CbGeAlD
Hexobarbital—CHRFAM7A—blood—hematologic cancer	0.00183	0.0242	CbGeAlD
Hexobarbital—GRIA2—testis—hematologic cancer	0.00166	0.0219	CbGeAlD
Hexobarbital—GABRA5—testis—hematologic cancer	0.00155	0.0205	CbGeAlD
Hexobarbital—CHRFAM7A—testis—hematologic cancer	0.00151	0.02	CbGeAlD
Hexobarbital—CHRNA7—blood—hematologic cancer	0.00147	0.0195	CbGeAlD
Hexobarbital—GABRA3—testis—hematologic cancer	0.00145	0.0191	CbGeAlD
Hexobarbital—CYP2C19—hematopoietic system—hematologic cancer	0.00143	0.0189	CbGeAlD
Hexobarbital—CHRNA4—lung—hematologic cancer	0.00128	0.0169	CbGeAlD
Hexobarbital—CHRNA7—testis—hematologic cancer	0.00122	0.0161	CbGeAlD
Hexobarbital—CYP1A2—hematopoietic system—hematologic cancer	0.00117	0.0155	CbGeAlD
Hexobarbital—CYP2C9—hematopoietic system—hematologic cancer	0.00111	0.0147	CbGeAlD
Hexobarbital—CYP2E1—hematopoietic system—hematologic cancer	0.00105	0.0139	CbGeAlD
Hexobarbital—PTGS1—hematopoietic system—hematologic cancer	0.00101	0.0134	CbGeAlD
Hexobarbital—CYP2C19—blood—hematologic cancer	0.000948	0.0125	CbGeAlD
Hexobarbital—CYP3A4—hematopoietic system—hematologic cancer	0.000846	0.0112	CbGeAlD
Hexobarbital—GABRA2—lymph node—hematologic cancer	0.000781	0.0103	CbGeAlD
Hexobarbital—CYP1A2—blood—hematologic cancer	0.000774	0.0102	CbGeAlD
Hexobarbital—CYP2C9—blood—hematologic cancer	0.000735	0.00972	CbGeAlD
Hexobarbital—CYP2E1—blood—hematologic cancer	0.000696	0.00921	CbGeAlD
Hexobarbital—CYP1A2—lung—hematologic cancer	0.000679	0.00898	CbGeAlD
Hexobarbital—PTGS1—blood—hematologic cancer	0.000671	0.00887	CbGeAlD
Hexobarbital—CYP2E1—lung—hematologic cancer	0.00061	0.00807	CbGeAlD
Hexobarbital—PTGS1—lung—hematologic cancer	0.000588	0.00778	CbGeAlD
Hexobarbital—CYP2E1—testis—hematologic cancer	0.000576	0.00762	CbGeAlD
Hexobarbital—CYP3A4—blood—hematologic cancer	0.00056	0.00741	CbGeAlD
Hexobarbital—PTGS1—testis—hematologic cancer	0.000555	0.00734	CbGeAlD
Hexobarbital—PTGS1—lymph node—hematologic cancer	0.000402	0.00532	CbGeAlD
Hexobarbital—CYP2C19—Metabolism—ACP5—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—HMMR—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—IDH2—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.02e-05	0.00011	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYCS—hematologic cancer	1.02e-05	0.000109	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MTR—hematologic cancer	1.02e-05	0.000109	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ABCG2—hematologic cancer	1.02e-05	0.000109	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.01e-05	0.000109	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ENO2—hematologic cancer	1e-05	0.000107	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—IDH1—hematologic cancer	9.76e-06	0.000104	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.76e-06	0.000104	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ARNTL—hematologic cancer	9.73e-06	0.000104	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTT1—hematologic cancer	9.7e-06	0.000104	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CDA—hematologic cancer	9.69e-06	0.000104	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TXN—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ABCC3—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTO1—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—FHL2—hematologic cancer	9.52e-06	0.000102	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—SDC1—hematologic cancer	9.48e-06	0.000101	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CA9—hematologic cancer	9.47e-06	0.000101	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ACP5—hematologic cancer	9.47e-06	0.000101	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SPHK1—hematologic cancer	9.45e-06	0.000101	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.35e-06	0.0001	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—AGRN—hematologic cancer	9.33e-06	9.98e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PC—hematologic cancer	9.33e-06	9.98e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.13e-06	9.77e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—UGT1A1—hematologic cancer	9.08e-06	9.71e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SLC35B2—hematologic cancer	9.01e-06	9.64e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GBA—hematologic cancer	9.01e-06	9.64e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTP1—hematologic cancer	9e-06	9.63e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—IDH1—hematologic cancer	8.9e-06	9.52e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—IDH2—hematologic cancer	8.85e-06	9.47e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—HMMR—hematologic cancer	8.85e-06	9.47e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.83e-06	9.45e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.83e-06	9.45e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.8e-06	9.42e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TXN—hematologic cancer	8.8e-06	9.42e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.8e-06	9.42e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.71e-06	9.32e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.61e-06	9.22e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.61e-06	9.21e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ABCB1—hematologic cancer	8.52e-06	9.11e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.34e-06	8.93e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NUP98—hematologic cancer	8.33e-06	8.92e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.32e-06	8.9e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.28e-06	8.85e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—NCOR1—hematologic cancer	8.27e-06	8.85e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTM1—hematologic cancer	8.27e-06	8.85e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MTAP—hematologic cancer	8.24e-06	8.82e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CA9—hematologic cancer	8.09e-06	8.66e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ACP5—hematologic cancer	8.09e-06	8.66e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ADCY7—hematologic cancer	8.09e-06	8.66e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NCOA3—hematologic cancer	8.09e-06	8.66e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CD44—hematologic cancer	8.06e-06	8.63e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NQO1—hematologic cancer	8.06e-06	8.63e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SLC22A1—hematologic cancer	8.05e-06	8.61e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CRABP1—hematologic cancer	8.05e-06	8.61e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NUP214—hematologic cancer	8.03e-06	8.59e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.99e-06	8.54e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.95e-06	8.51e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MTR—hematologic cancer	7.87e-06	8.42e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.87e-06	8.42e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.85e-06	8.39e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ENO2—hematologic cancer	7.72e-06	8.26e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYCS—hematologic cancer	7.63e-06	8.16e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—IDH1—hematologic cancer	7.61e-06	8.14e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NUP98—hematologic cancer	7.6e-06	8.13e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	7.58e-06	8.11e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TXN—hematologic cancer	7.52e-06	8.05e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.52e-06	8.05e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.52e-06	8.05e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.49e-06	8.01e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.38e-06	7.89e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.38e-06	7.89e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.37e-06	7.89e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.36e-06	7.88e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—FHL2—hematologic cancer	7.34e-06	7.86e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NUP214—hematologic cancer	7.33e-06	7.84e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SDC1—hematologic cancer	7.32e-06	7.83e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MTHFR—hematologic cancer	7.31e-06	7.82e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.25e-06	7.76e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—AGRN—hematologic cancer	7.2e-06	7.71e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MTR—hematologic cancer	7.18e-06	7.68e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.18e-06	7.68e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—UGT1A1—hematologic cancer	7.07e-06	7.57e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ENO2—hematologic cancer	7.04e-06	7.53e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.99e-06	7.48e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.9e-06	7.38e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.88e-06	7.36e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.88e-06	7.36e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—IDH2—hematologic cancer	6.83e-06	7.3e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—HMMR—hematologic cancer	6.83e-06	7.3e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.83e-06	7.3e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTP1—hematologic cancer	6.73e-06	7.2e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.72e-06	7.19e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.7e-06	7.17e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SDC1—hematologic cancer	6.67e-06	7.14e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.6e-06	7.06e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NUP98—hematologic cancer	6.49e-06	6.95e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.44e-06	6.89e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.42e-06	6.87e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.37e-06	6.82e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ABCB1—hematologic cancer	6.37e-06	6.81e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.3e-06	6.74e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.3e-06	6.74e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.29e-06	6.73e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NUP214—hematologic cancer	6.26e-06	6.7e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CA9—hematologic cancer	6.24e-06	6.68e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ACP5—hematologic cancer	6.24e-06	6.68e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CD44—hematologic cancer	6.22e-06	6.66e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NQO1—hematologic cancer	6.22e-06	6.66e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.19e-06	6.63e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NCOR1—hematologic cancer	6.18e-06	6.61e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTM1—hematologic cancer	6.18e-06	6.61e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.16e-06	6.59e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3CG—hematologic cancer	6.14e-06	6.57e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MTR—hematologic cancer	6.13e-06	6.56e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.13e-06	6.56e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.09e-06	6.52e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.02e-06	6.44e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ENO2—hematologic cancer	6.01e-06	6.43e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYCS—hematologic cancer	5.89e-06	6.3e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—IDH1—hematologic cancer	5.87e-06	6.28e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.85e-06	6.26e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.83e-06	6.24e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.81e-06	6.21e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TXN—hematologic cancer	5.81e-06	6.21e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.81e-06	6.21e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.74e-06	6.14e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SDC1—hematologic cancer	5.7e-06	6.1e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CREBBP—hematologic cancer	5.69e-06	6.09e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.68e-06	6.08e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CD44—hematologic cancer	5.67e-06	6.07e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NQO1—hematologic cancer	5.67e-06	6.07e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.55e-06	5.94e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MTHFR—hematologic cancer	5.46e-06	5.84e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.46e-06	5.84e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.45e-06	5.83e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3CD—hematologic cancer	5.4e-06	5.78e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.38e-06	5.75e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYCS—hematologic cancer	5.37e-06	5.74e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.33e-06	5.71e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ALB—hematologic cancer	5.33e-06	5.7e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.31e-06	5.68e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.31e-06	5.68e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.26e-06	5.63e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.19e-06	5.55e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.17e-06	5.54e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.14e-06	5.5e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3R1—hematologic cancer	5.1e-06	5.45e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.02e-06	5.37e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NUP98—hematologic cancer	5.01e-06	5.36e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.91e-06	5.25e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.87e-06	5.21e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.87e-06	5.21e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CD44—hematologic cancer	4.85e-06	5.19e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NQO1—hematologic cancer	4.85e-06	5.19e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NUP214—hematologic cancer	4.83e-06	5.17e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.8e-06	5.14e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.77e-06	5.1e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.77e-06	5.1e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.75e-06	5.08e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MTR—hematologic cancer	4.73e-06	5.06e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.73e-06	5.06e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.73e-06	5.06e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.71e-06	5.03e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ENO2—hematologic cancer	4.64e-06	4.97e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.59e-06	4.91e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYCS—hematologic cancer	4.59e-06	4.91e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.58e-06	4.9e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.56e-06	4.88e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.5e-06	4.82e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.48e-06	4.79e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SDC1—hematologic cancer	4.4e-06	4.71e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.35e-06	4.65e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.35e-06	4.65e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.25e-06	4.55e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.21e-06	4.51e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.1e-06	4.39e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PTEN—hematologic cancer	4.07e-06	4.35e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.04e-06	4.33e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3CD—hematologic cancer	4.03e-06	4.32e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ALB—hematologic cancer	3.98e-06	4.26e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.91e-06	4.18e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—EP300—hematologic cancer	3.88e-06	4.15e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.84e-06	4.11e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.83e-06	4.09e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.81e-06	4.08e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NQO1—hematologic cancer	3.74e-06	4e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CD44—hematologic cancer	3.74e-06	4e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.72e-06	3.97e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.72e-06	3.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.71e-06	3.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.54e-06	3.79e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYCS—hematologic cancer	3.54e-06	3.79e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.52e-06	3.76e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.52e-06	3.76e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.39e-06	3.62e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.28e-06	3.51e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.28e-06	3.51e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.23e-06	3.45e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.12e-06	3.34e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.11e-06	3.33e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ALB—hematologic cancer	3.07e-06	3.29e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PTEN—hematologic cancer	3.04e-06	3.25e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.99e-06	3.2e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.95e-06	3.16e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.94e-06	3.14e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—EP300—hematologic cancer	2.9e-06	3.1e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.89e-06	3.1e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.87e-06	3.07e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.87e-06	3.07e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.87e-06	3.07e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.84e-06	3.04e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ALB—hematologic cancer	2.8e-06	3e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.76e-06	2.95e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.71e-06	2.9e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.68e-06	2.87e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.56e-06	2.74e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.53e-06	2.71e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.47e-06	2.65e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.43e-06	2.59e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ALB—hematologic cancer	2.39e-06	2.56e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PTEN—hematologic cancer	2.34e-06	2.51e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—AKT1—hematologic cancer	2.34e-06	2.51e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.29e-06	2.45e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—EP300—hematologic cancer	2.24e-06	2.39e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PTEN—hematologic cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.13e-06	2.28e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.11e-06	2.26e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—EP300—hematologic cancer	2.04e-06	2.18e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.97e-06	2.11e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.87e-06	2e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ALB—hematologic cancer	1.85e-06	1.98e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PTEN—hematologic cancer	1.83e-06	1.95e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.77e-06	1.89e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—AKT1—hematologic cancer	1.75e-06	1.87e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—EP300—hematologic cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.65e-06	1.77e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.63e-06	1.75e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.51e-06	1.61e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PTEN—hematologic cancer	1.41e-06	1.51e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—AKT1—hematologic cancer	1.35e-06	1.45e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—EP300—hematologic cancer	1.34e-06	1.44e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.29e-06	1.38e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—AKT1—hematologic cancer	1.23e-06	1.32e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—AKT1—hematologic cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.95e-07	1.06e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—AKT1—hematologic cancer	8.12e-07	8.69e-06	CbGpPWpGaD
